Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Mattioli

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Journal of Parkinson'S Disease|July 11, 2022
The Role of Monoaminergic Tones and Brain Metabolism in Cognition in De Novo Parkinson's DiseaseBeatrice Orso, Dario Arnaldi, Enrico Peira, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2022
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson's Disease (PD) and dementia with Lewy bodies (DLB)Francesco Lanfranchi, Dario Arnaldi, Alberto Miceli, et al.
Neurobiology of Disease|July 3, 2025
[<sup>18</sup>F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's diseaseVirginia Pelagotti, Domenico Plantone, Francesca D'Amico, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2025
Longitudinal changes in [<sup>18</sup>F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitisDenise Cerne, Stefano Raffa, Giulia Benvenuto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's diseaseFederico Massa, Andrea Chincarini, Matteo Bauckneht, et al.
Scientific Reports|February 5, 2025
Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathiesOliver C Kiersnowski, Pietro Mattioli, Lucia Argenti, et al.
Journal of Parkinson'S Disease|December 3, 2025
MRI susceptibility map weighted imaging (SMWI) as a neurodegeneration biomarker in the prodromal to overt alpha-synucleinopathy continuumLaura Falcitano, Francesco Calizzano, Pietro Mattioli, et al.
European Journal of Neurology|April 22, 2025
The Many Faces of REM Sleep Behavior Disorder. Providing Evidence for a New LexiconDario Arnaldi, Pietro Mattioli, Beatrice Orso, et al.
Journal of Neurology|September 26, 2024
Validation of the International REM Sleep Behavior Disorder Study Group Symptoms Severity Scale (IRBD-SSS): a new tool to assess RBD clinical severityMaria Livia Fantini, Ronald B Postuma, Monica Puligheddu, et al.
Journal of Neurology|December 29, 2023
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's diseaseFederico Massa, Caterina Martinuzzo, Nerea Gómez de San José, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Journal of Parkinson'S Disease|July 11, 2022
The Role of Monoaminergic Tones and Brain Metabolism in Cognition in De Novo Parkinson's DiseaseBeatrice Orso, Dario Arnaldi, Enrico Peira, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 5, 2022
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson's Disease (PD) and dementia with Lewy bodies (DLB)Francesco Lanfranchi, Dario Arnaldi, Alberto Miceli, et al.
Neurobiology of Disease|July 3, 2025
[<sup>18</sup>F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's diseaseVirginia Pelagotti, Domenico Plantone, Francesca D'Amico, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2025
Longitudinal changes in [<sup>18</sup>F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitisDenise Cerne, Stefano Raffa, Giulia Benvenuto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's diseaseFederico Massa, Andrea Chincarini, Matteo Bauckneht, et al.
Scientific Reports|February 5, 2025
Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathiesOliver C Kiersnowski, Pietro Mattioli, Lucia Argenti, et al.
Journal of Parkinson'S Disease|December 3, 2025
MRI susceptibility map weighted imaging (SMWI) as a neurodegeneration biomarker in the prodromal to overt alpha-synucleinopathy continuumLaura Falcitano, Francesco Calizzano, Pietro Mattioli, et al.
European Journal of Neurology|April 22, 2025
The Many Faces of REM Sleep Behavior Disorder. Providing Evidence for a New LexiconDario Arnaldi, Pietro Mattioli, Beatrice Orso, et al.
Journal of Neurology|September 26, 2024
Validation of the International REM Sleep Behavior Disorder Study Group Symptoms Severity Scale (IRBD-SSS): a new tool to assess RBD clinical severityMaria Livia Fantini, Ronald B Postuma, Monica Puligheddu, et al.
Journal of Neurology|December 29, 2023
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's diseaseFederico Massa, Caterina Martinuzzo, Nerea Gómez de San José, et al.
Pageof 7